Advertisement

Current Treatment Options in Allergy

, Volume 5, Issue 1, pp 133–139 | Cite as

How Can We Influence the Performance of Drug Challenge in Future Treatment

  • Aslı Gelincik
  • Gülfem E. Celik
Drug Allergy (MJ Torres Jaén, Section Editor)
  • 41 Downloads
Part of the following topical collections:
  1. Topical Collection on Drug Allergy

Abstract

Drug provocation tests are assumed to be the gold standard of drug allergy workup by ensuring the most objective results in clinical observation irrespective of the underlying mechanism of the reaction. Despite its some disadvantages, it is still one of the cornerstones of the drug allergy diagnosis. In this review, new methods for improving diagnostic accuracy of drug provocation tests will be discussed. In this sense, extended challenges are recently shown to have better outcome especially in diagnosing non-immediate reactions due to antibiotics. In children with non-immediate mild cutaneous reactions, provocation tests are becoming to take place of skin tests with promising results. Furthermore, drug provocation tests have been shown to prevent unnecessary desensitization protocols in newly developed drugs such as biological agents. These new data on diagnostic performance of drug provocation test seem to influence the future treatments in patients with drug hypersensitivity reactions.

Keywords

Drug provocation tests Extended provocation Drug allergy Non-immediate reactions Beta-lactams 

Notes

Compliance With Ethical Standards

Conflict of Interest

Aslı Gelincik declares that she has no conflict of interest.

Gülfem E. Celik declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as• Of importance •• Of major importance

  1. 1.
    Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011;127(3 Suppl):S67–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–73.  https://doi.org/10.1016/j.anai.2010.08.002.CrossRefGoogle Scholar
  3. 3.
    Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420–37.  https://doi.org/10.1111/all.12350.CrossRefPubMedGoogle Scholar
  4. 4.
    Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.PubMedGoogle Scholar
  5. 5.•
    Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs—an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702–12.  https://doi.org/10.1111/all.12142. Principals of drug skin tests are mentioned in detail in this review.
  6. 6.•
    Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854–63.  https://doi.org/10.1034/j.1398-9995.2003.00279.x. Principals of DPTs are outlined in this review.CrossRefPubMedGoogle Scholar
  7. 7.•
    Soyer O, Sahiner UM, Sekerel BE. Pro and contra: provocation tests in drug hypersensitivity. Int J Mol Sci. 2017;18(7):1437.  https://doi.org/10.3390/ijms18071437. Overview of considerations in DPT.
  8. 8.
    Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Cernadas JR, et al. In vitro tests for drug hypersensitivity reactions. An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016;71(8):1103–34.  https://doi.org/10.1111/all.12886.CrossRefPubMedGoogle Scholar
  9. 9.••
    Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016;71(2):149–61.  https://doi.org/10.1111/all.12774. Significance of DPT in pediatric population and its value without prior skin testing in non-immediate mild cutaneous reactions in children are outlined.
  10. 10.
    Demir S, Gelincik A, Akdeniz N, Aktas-Cetin E, Olgac M, Unal D, et al. Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin. Allergy Asthma Immunol Res. 2017;9(4):347–59.  https://doi.org/10.4168/aair.2017.9.4.347.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Demir S, Olgac M, Unal D, Gelincik A, Colakoglu B, Buyukozturk S. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015;70(11):1461–7.  https://doi.org/10.1111/all.12689.CrossRefPubMedGoogle Scholar
  12. 12.••
    Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Urena-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P, et al. Delving into cornerstones of hypersensitivity to antineoplatic and biological agents: value of diagnostic tools prior to desensitization. Allergy. 2015;70(7):784–94.  https://doi.org/10.1111/all.12620. This study presented the importance of DPT in preventing unnecessary desensitizations for hypersensitivity reactions due to chemotherapeutic drugs and biological agents.CrossRefPubMedGoogle Scholar
  13. 13.
    Çelik G, Erkekol FO, Bavbek S, Dursun AB, Mısırlıgil Z. Long term use of COX-2 inhibitors in patients with analgesic intolerance. Ann Allergy Asthma Immunol. 2005;95(1):33–7.  https://doi.org/10.1016/S1081-1206(10)61185-4.CrossRefPubMedGoogle Scholar
  14. 14.
    Misirlioglu ED, Toyran M, Capanoglu M, Kaya A, Civelek E, Kocabas CN. Negative predictive value of drug provocation tests in children. Pediatr Allergy Immunol. 2014;25(7):685–90.  https://doi.org/10.1111/pai.12286.CrossRefPubMedGoogle Scholar
  15. 15.
    Demoly P, Romano A, Botelho C, Bousquet-Rouanet L, Gaeta F, Silva R, et al. Determining the negative predictive value ofprovocation tests with beta-lactams. Allergy. 2010;65(3):327–32.  https://doi.org/10.1111/j.1398-9995.2009.02228.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Çapanoglu M, Vezir E, Misirlioglu ED, Guvenir H, Buyuktiryaki B, Toyran M, et al. Additional provocation testing in patients with negative provocation test results with β-lactam antibiotics. Ann Allergy Asthma Immunol. 2016;116(1):82–3.  https://doi.org/10.1016/j.anai.2015.10.010.CrossRefPubMedGoogle Scholar
  17. 17.
    Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy. 2004;59(11):1153–60.  https://doi.org/10.1111/j.1398-9995.2004.00678.x.CrossRefPubMedGoogle Scholar
  18. 18.
    Chiriac AM, Rerkpattanapipat T, Bousquet PJ, Molinari N, Demoly P. Optimal step doses for drug provocation tests to prove β-lactam hypersensitivity. Allergy. 2017;72(4):552–61.  https://doi.org/10.1111/all.13037.CrossRefPubMedGoogle Scholar
  19. 19.
    Borch JE, Bindslev-Jensen C. Full-course drug challenge test in the diagnosis of delayed allergic reactions to penicillin. Int Arch Allergy Immunol. 2011;155(3):271–4.  https://doi.org/10.1159/000320384.CrossRefPubMedGoogle Scholar
  20. 20.
    Mori F, Cianferoni A, Barni S, Pucci N, Rossi ME, Novembre E. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. J Allergy Clin Immunol Pract. 2015;3(3):375–80.e1.  https://doi.org/10.1016/j.jaip.2014.11.001.CrossRefPubMedGoogle Scholar
  21. 21.
    Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy. 2013;68(8):1057–64.  https://doi.org/10.1111/all.12195.CrossRefPubMedGoogle Scholar
  22. 22.
    Lezmi G, Alrowaishdi F, Bados-Albiero A, Scheinmann P, de Blic J, Ponvert C. Non-immediate-reading skin tests and prolonged challenges in non-immediate hypersensitivity to beta-lactams in children. Pediatr Allergy Immunol. 2017;  https://doi.org/10.1111/pai.12826.
  23. 23.
    Ratzon R, Reshef A, Efrati O, Deutch M, Forschmidt R, Cukierman-Yaffe T, et al. Impact of an extended challenge on the effectiveness of β-lactam hypersensitivity investigation. Ann Allergy Asthma Immunol. 2016;116(4):329–33.  https://doi.org/10.1016/j.anai.2016.01.018.CrossRefPubMedGoogle Scholar
  24. 24.
    Mill C, Primeau MN, Medoff E, Lejtenyi C, O'Keefe A, Netchiporouk E, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr. 2016;170(6):e160033.  https://doi.org/10.1001/jamapediatrics.2016.0033.CrossRefPubMedGoogle Scholar
  25. 25.
    Vezir E, Dibek Misirlioglu E, Civelek E, Capanoglu M, Guvenir H, Ginis T, et al. Direct oral provocation tests in non-immediate mild cutaneous reactions related to beta-lactam antibiotics. Pediatr Allergy Immunol. 2016;27(1):50–4.  https://doi.org/10.1111/pai.12493.CrossRefPubMedGoogle Scholar
  26. 26.
    Marrs T, Fox AT, Lack G, du Toit G. The diagnosis and management of antibiotic allergy in children: systematic review to inform a contemporary approach. Arch Dis Child. 2015;100(6):583–8.  https://doi.org/10.1136/archdischild-2014-306280.CrossRefPubMedGoogle Scholar
  27. 27.
    Picard M, Regnier Galvao V. Current knowledge and management of hypersensitivity reactions to monoclonal antbodies. J Allergy Clin Immunol Pract. 2017;5(3):600–9.  https://doi.org/10.1016/j.jaip.2016.12.001.CrossRefPubMedGoogle Scholar
  28. 28.
    Vultaggio A, Maggi E, Matucci A. Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management. Curr Opin Allergy Clin Immunol. 2011;11(3):262–8.  https://doi.org/10.1097/ACI.0b013e3283464bcd.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Internal Medicine, Division of Immunology and AllergyIstanbul University School of MedicineIstanbulTurkey
  2. 2.Department of Chest Diseases, Division of Immunology and AllergyAnkara University School of MedicineAnkaraTurkey

Personalised recommendations